Latest News and Press Releases

GE为西比曼加速CAR-T细胞治疗药物的临床试验及未来商业化进程提供生产支持西比曼上海工厂将成为全球首个采用GE医疗细胞治疗灵活生产平台（FlexFactoryTM）技术的细胞治疗产品生产设施，并配备功能完善且可扩展的细胞治疗生产能力、培训及服务 中国上海及美国加州库比蒂诺市, Jan. 20, 2018 (GLOBE NEWSWIRE) --...

GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization First GE Healthcare FlexFactory™ for cell therapy installation...

SHANGHAI, China and CUPERTINO, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...

SHANGHAI, China and CUPERTINO, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical company engaged...

SHANGHAI, China and CUPERTINO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- 11月4日，国内领先细胞治疗生物科技公司西比曼生物科技集团（Cellular Biomedicine Group, NASDAQ:...

SHANGHAI, China and CUPERTINO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...

SHANGHAI, China and CUPERTINO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- 国内领先细胞治疗生物科技公司西比曼生物科技集团（Cellular Biomedicine Group,...

SHANGHAI, China and CUPERTINO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm...

SHANGHAI, China and CUPERTINO, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...

SHANGHAI, China and CUPERTINO, Calif., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...